| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.00 / 0.00 |
| Exchange | NYSE |
| Div & Yield | N.A. (N.A) |
Trade-Ideas LLC identified Hospira (HSP) as a new lifetime high candidate
So far in 2015, the health care sector has been outpacing the general market.
Stocks were rattled this week by Greece's impending default, causing the S&P 500 barely eek out a gain for the first half of the year. Netflix's stock has nearly doubled.
It's no secret companies like Apple, Google and Pfizer are sitting on piles of cash. The question is what they plan to do with all that money.
Trade-Ideas LLC identified Hospira (HSP) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Health care deals dominate the list of big mergers so far this year, while tech comes in second.
Trade-Ideas LLC identified Hospira (HSP) as a new lifetime high candidate
Trade-Ideas LLC identified Hospira (HSP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
It's a myth that regulators rely on covenants allocating antitrust risk for merger investigations; such agreements hardly play a role in the government analysis of a competition threat, regulators say.
On the heels of Nokia's proposed Alcatel Lucent purchase, here's a closer look at what to do with a stock after a M&A, regardless of whether you already own it.
Mega deals from strategic players across a variety of industries pushed first-quarter deals to the highest value since 2007.
Trade-Ideas LLC identified Hospira (HSP) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Health care is a hot investment sector, but some of the industry's best performers last quarter included well-known big benefits companies.
What do Kohl's, First Solar and Kraft Foods have in common? They are among the best performing stocks in 2015.
This market is leaving a bad taste in the mouths of many investors, Cramer says.
Valeant comes out on top, following a competing bid from Endo International for the gastrointestinal drugmaker Salix.
Investors can grow their portfolios with this simple and effective strategy: Buy, forget and collect.
Following last year's failed attempt to purchase Allergan, the Canadian pharmaceutical giant continues its acquisition strategy with its latest deal.
Rigrodsky & Long, P.A.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Hospira, Inc.
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Hospira Inc.
Rigrodsky & Long, P.A.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hospira,...
Levi & Korsinsky is commencing an investigation into the Board of Directors of Hospira Inc.
The logic of owning the pure play is attractive.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hospira,...
Pfizer’s stock jumped 3% in trading on Thursday morning following the company’s announcement on February 5th to acquire fellow pharmaceutical company, Hospira for $17 billion. Sign up for¿...
Kirby McInerney LLP is investigating potential claims against Hospira, Inc.
